NasdaqCM - Delayed Quote • USD
Exact Sciences Corporation (EXAS)
At close: May 9 at 4:00 PM EDT
Pre-Market: 4:59 AM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 16 | 16 | 18 | 17 |
| Avg. Estimate | -0.23 | -0.11 | -0.85 | 0.06 |
| Low Estimate | -0.34 | -0.31 | -1.29 | -0.64 |
| High Estimate | -0.09 | 0.05 | -0.31 | 0.81 |
| Year Ago EPS | -0.45 | 0 | -1.13 | -0.85 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 20 | 20 | 22 | 21 |
| Avg. Estimate | 700.15M | 732.02M | 2.83B | 3.23B |
| Low Estimate | 682M | 713.3M | 2.82B | 3.17B |
| High Estimate | 721.08M | 751M | 2.87B | 3.36B |
| Year Ago Sales | 622.09M | 616.81M | 2.5B | 2.83B |
| Sales Growth (year/est) | 12.50% | 18.70% | 13.30% | 13.90% |
Earnings History
| CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.51 | -0.48 | -0.46 | -0.47 |
| EPS Actual | -0.45 | 0 | -0.27 | -0.6 |
| Difference | 0.06 | 0.48 | 0.19 | -0.13 |
| Surprise % | 11.80% | 100.00% | 41.30% | -27.70% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.23 | -0.11 | -0.85 | 0.06 |
| 7 Days Ago | -0.23 | -0.11 | -0.85 | 0.06 |
| 30 Days Ago | -0.23 | -0.11 | -0.84 | 0.06 |
| 60 Days Ago | -0.22 | -0.1 | -0.82 | 0.08 |
| 90 Days Ago | -0.25 | -0.19 | -0.99 | 0.09 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | 1 | 1 | 1 | 2 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | EXAS | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 48.90% | -- | -- | 8.60% |
| Next Qtr. | -- | -- | -- | 11.90% |
| Current Year | 24.80% | -- | -- | 5.60% |
| Next Year | 107.10% | -- | -- | 13.20% |
| Next 5 Years (per annum) | 98.50% | -- | -- | 11.07% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | BTIG: Buy to Buy | 5/9/2024 |
| Maintains | Canaccord Genuity: Buy to Buy | 5/9/2024 |
| Maintains | Citigroup: Buy to Buy | 5/9/2024 |
| Maintains | Citigroup: Buy to Buy | 4/3/2024 |
| Maintains | Canaccord Genuity: Buy to Buy | 2/22/2024 |
| Upgrade | Benchmark: Hold to Buy | 1/2/2024 |
Related Tickers
GH Guardant Health, Inc.
19.44
+4.29%
ILMN Illumina, Inc.
111.35
+0.66%
TWST Twist Bioscience Corporation
43.20
+4.35%
NTRA Natera, Inc.
95.55
-0.11%
MYGN Myriad Genetics, Inc.
25.25
+5.43%
OPK OPKO Health, Inc.
1.2600
+0.80%
TMO Thermo Fisher Scientific Inc.
577.93
+0.75%
VCYT Veracyte, Inc.
20.63
+2.53%
WAT Waters Corporation
336.42
+3.90%
IDXX IDEXX Laboratories, Inc.
500.82
+2.82%